What is Pacemate?
PaceMate operates at the intersection of healthcare and technology, offering a sophisticated cardiac device monitoring platform. This solution is specifically engineered to empower integrated delivery networks and academic health systems. By consolidating data from diverse device manufacturers and electronic health record systems, PaceMate provides a unified, intelligent digital platform that enhances the efficiency of managing and monitoring patients with cardiac devices.
How much funding has Pacemate raised?
Pacemate has raised a total of $8M across 1 funding round:
Series A
$8M
Series A (2021): $8M with participation from Ballast Point Ventures LP
Key Investors in Pacemate
Ballast Point Ventures LP
Ballast Point Ventures LP is an investment firm that typically backs companies in various stages of growth. Their participation suggests confidence in PaceMate's market position and future potential within the healthcare technology sector.
What's next for Pacemate?
The recent major enterprise-level funding indicates a strategic move by Pacemate to accelerate its growth and market penetration. This capital is likely to be deployed towards further development of its innovative cardiac monitoring technology, expanding its reach within healthcare systems, and potentially exploring new therapeutic areas or data analytics capabilities. The company's focus on integrated delivery networks and academic health systems positions it for significant impact in improving patient care and operational efficiency within complex healthcare environments.
See full Pacemate company page
